Alpha Teknova, Inc. (TKNO) Financial Analysis & Valuation | Quarter Chart
Alpha Teknova, Inc. (TKNO)
TKNOPrice: $2.73
Fair Value: 🔒
🔒score
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-po... more
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and int... more
Description
Shares
| Market Cap | $146.03M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Stephen Gunstream |
| IPO Date | 2021-06-25 | CAGR | 0.12% |
| Employees | 173 | Website | www.teknova.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TKNO chart loading...
Fundamentals
Technicals
| Enterprise Value | $212.70M | P/E Ratio | -12.08 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 3.6 | P/B Ratio | 2.12 |
| P/CF Ratio | -17.28 | P/FCF Ratio | -15.22 |
| EPS | $-0.39 | EPS Growth 1Y | -46.93% |
| EPS Growth 3Y | -80.85% | EPS Growth 5Y | -729.77% |
| Revenue Growth 1Y | 7.35% | Gross Margin | 0.33% |
| Operating Margin | -0.42% | Profit Margin | -0.43% |
| ROE | -0.23% | ROA | -0.17% |
| ROCE | -0.18% | Current Ratio | 4.58 |
| Quick Ratio | 3.64 | Cash Ratio | 0.78 |
| Debt/Equity | 0.22 | Interest Coverage | -23.91 |
| Altman Z Score | 0.9 | Piotroski Score | 4 |